Dr. Mustafa Kamal Ansari, MD

Dr. Ansari practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Ansari's NPI, 1396088258, was assigned on March 29, 2013. Dr. Ansari graduated from UTMB Health in 2013. Dr. Ansari holds California license A133804.

Dr. Ansari's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Ansari's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. Dr. Ansari is also affiliated with Oroville Hospital. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Ansari to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ansari practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Ansari's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Ansari is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Ansari is licensed in California.

Dmand AI lists encephalopathy, epilepsy, fibromyalgia and chronic pain, hereditary polyneuropathy, lower back pain, migraine and chronic headache, mobility impairment and multiple sclerosis among the conditions Dr. Ansari treats.

CMS data shows 482 Medicare services from Dr. Ansari across 6 procedure codes in 2024, for 233 Medicare patients. Medicare paid $28,136 for them. Every service was in an office.

CMS counts 233 Medicare patients who saw Dr. Ansari in 2024. The largest group is under 65, with 77 patients. 70% of them have high cholesterol, and 61% have high blood pressure. 37% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ansari's median patient age at 53, with 71% women.

In 2024, Dr. Ansari wrote 830 Medicare Part D claims for 95 patients. 74% of them were for generic drugs. CMS names the drug for 601 of them, across 24 drugs with 11 or more claims each, at $725,652 in total drug cost. In 2023, CMS named 588 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Ansari for performance year 2024, reported as part of a group. Dr. Ansari accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ansari as offering telehealth.

Dmand AI links 5 papers to Dr. Ansari, published from 2016 to 2025. The most frequent topics are Oxidative Stress. Dr. Ansari's most frequent co-authors are Lilyana Amezcua, MD, Gregory Y. Chang, MD and Michael Jon Levy, MD.

Dmand AI links Dr. Ansari to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Encephalitis and Neuroinflammatory Diseases.

CMS Open Payments shows 10 general payments to Dr. Ansari from 5 drug and device companies from 2017 to 2023. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $261.

Dr. Ansari graduated from UTMB Health in 2013. Dr. Ansari is a member of AAN.

Dr. Ansari is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.